Answers are grounded in this paper and cite their sources.
This approach utilizes multimodal deep learning to enhance classification accuracy in Alzheimer’s disease, suggesting integration of MRI and clinical records benefits diagnosis.
Alzheimer's disease (AD) is a neurodegenerative disorder that strikes millions of people globally. Classification that is both accurate and early-stage is key to successful intervention and treatment planning. In this paper, AlzFusionNet, a multimodal deep learning model fusing MRI features with clinical information for enhanced AD classification, is proposed. EfficientNet-B7 is used as the backbone of the model to extract MRI features, and PCA is used to decrease the dimensionality of clinical information. A fusion layer merges both modalities for four-stage classification: Non-Demented, Very Mild Demented, Mild Demented, and Moderate Demented. Experimental outcomes prove that AlzFusionNet outperforms single-modality models in terms of accuracy (96.8%). The results underscore the advantages of multimodal integration for AD classification.
No takes yet. Share an insight, caveat, or question.
Modi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: